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This review presents a global view of the current situation of the scientific knowledge 1 
about aspects of wine with possible repercussions (positive or negative) on consumer 2 
health and wine safety. The presence in wine of some potential harmful compounds such 3 
as phytosanitary products, trace metal compounds, sulfites and some toxics from 4 
microbial origin, such as ochratoxin A, ethyl carbamate and biogenic amines, is 5 
discussed. The different strategies and alternative methodologies that are being carried 6 
out to reduce or to avoid the presence of these substances in wines are also discussed. 7 
In recent years many work has been focused on establishing the scientific explanations 8 
for the positive biological effects of some wine compounds. In this review, we also 9 
examine the latest knowledge regarding wine and health, focusing in two types of 10 
compounds that have been related to the positive effects of moderate wine consumption 11 
such as phenolic compounds and bioactive peptides.  12 
 13 
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INTRODUCTION  1 
 2 
The intense changes in society’s life style over the past few years have had 3 
significant effects on the basic concepts of our eating habits. Nowadays, we can go 4 
further than the traditional idea of what should be a ‘suitable diet’ in the sense that it 5 
should provide the sufficient nutrients to ensure individuals’ survival, satisfy metabolic 6 
requirements and pleasurably appease the sensation of hunger and wellbeing.  Today, it 7 
is also necessary to comply with aspects of health and safety, emphasizing the potential 8 
of foods from a health perspective, to increase wellbeing and to reduce the risk of 9 
illnesses.  10 
In an attempt to guarantee food safety for the consumer, several organizations 11 
such as the Food and Agriculture Organisation (FAO) of the United Nations and the 12 
World Health Organisation (WHO), among others, assess the health quality of foods in 13 
general, and also of wine. However, for aspects related to wine safety there is also 14 
another authority, the International Organisation of Vine and Wine (OIV), which, 15 
among other objectives, helps to protect consumer’s health, improving and guiding 16 
research on health aspects and spreading out the results of this research to healthcare 17 
professionals. Within this Organisation, which encloses several Commissions and 18 
Subcomissions, the Safety and Health Commission, is included. This group of experts is 19 
mainly focused on food safety, wine consumption, nutrition and health. 20 
In recent years, the topic ‘wine and health’ has aroused much interest but also 21 
considerable controversy. This is support by the large number of studies and scientific 22 
contributions that has been carried out within this area. In this review, we have 23 
summarised the main contributions of current knowledge about aspects of wine and its 24 
components that could affect safety and consumer’s health. We do not specially focus 25 
 4 
on alcohol, a wine ingredient with evident and well-known toxic effects, but instead on 1 
wine as a food, that can have beneficial effects on the health of healthy adult consumers 2 
when it is drunk in moderation. Nevertheless, wine may contain certain compounds that 3 
decrease the wholesomeness of wine such as chemical preservatives (sulphites), 4 
neurotoxins (ochratoxin A), potential carcinogens (ethyl carbamate) and allergens 5 
(biogenic amines), amongst others. Therefore, besides the need to examine the main 6 
causes of wine spoilage that may affect human health, this article also discusses the 7 
strategies followed to eliminate or minimise wine contamination. The latest studies 8 
about those compounds involved in positive health aspects of wine are also reviewed.   9 
 10 
COMPOUNDS PRESENT IN WINE WITH POTENTIALLY NEGATIVE HEALTH 11 
EFFECTS. METHODS FOR THEIR CONTROL AND PREVENTION 12 
 13 
Over the past few years, numerous research studies have focused on establishing 14 
the components of wine that can negatively affect the health of moderate wine drinkers, 15 
with the ultimate objective of searching for solutions to decrease or to avoid their 16 
presence in wines. The compounds that can damage wine’s health quality include those 17 
derived from the grape, which can appear as contaminants (i.e. pesticides and other 18 
phytosanitary products, trace metal compounds, additives such as SO2, which is added 19 
during different steps of the wine production process), and those produced by different 20 
microorganisms during winemaking including, ochratoxin A, ethyl carbamate and 21 





Phytosanitary products  1 
 Nowadays, a wide range of insecticides, fungicides and herbicides are used in 2 
grape production. In particular, grapes are especially vulnerable to moulds, which leads 3 
to the widespread use of antifungal agents. In Mediterrenean countries, the principal 4 
parasites of vine are the grape moth (Lobesia botrana), downy mildew (Plasmopora 5 
viticola), powdery mildew (Unicinula necator) and gray mold (Botrytis cinerea). The 6 
latter, if conditions are appropriate, may attack bunches of grapes damaging the grape, 7 
by synthesizing the enzymes required to breakdown the cell walls of the skin and 8 
penetrate in the flesh. To control these parasites, insecticides and fungicides are 9 
commonly used. In practise, to tackle this and other alterations, it is much more 10 
effective to use preventive treatments in order to maintain the vine whole and improve 11 
the quality of the grape. Although the correct use of pesticides does not cause 12 
environmental problems or public health concerns, if an inappropriate and abusive 13 
pesticide treatment is carried out, undesirable residues may remain on the grapes after 14 
harvest. As a result, they may be transferred into the wine. A more detailed review in 15 
this area was published by Cabras and Angioni (2000). 16 
With the aim to improve hygienic and sanitary characteristics of wines, the 17 
effect of some wine-making practices on the concentration and disappearance of 18 
pesticide residues during wine production has been evaluated (Cabras et al., 1995, 19 
Navarro et al., 1997, Soleas and Goldberg, 2000). Recently, some clarification and 20 
filtration processes have proved to be effective against four commonly used fungicides 21 
(cypronidil, fludioxonil, pyrimethanil, and quinoxyfen) for the control of cryotogramic 22 
vineyard diseases (Fernández et al., 2005). The most common clarifying substances for 23 
wine are bentonite, charcoal, gelatin, polyvinylpyrrolidone, potassium caseinate, and 24 
coloidal silicon dioxide. While most of them show limited ability to decrease pesticide 25 
 6 
residues, charcoal is especially recommended when the amount of residues is low, 1 
allowing the complete elimination of most pesticides. Its effectiveness generally 2 
decreases as the pesticide water solubility increases; therefore, pesticides highly soluble 3 
in water, such as dichlorvos and dimethoate, do not show appreciable changes (Cabras 4 
et al., 1995).  5 
 The activity of yeast and lactic acid bacteria involved in alcoholic and malolactic 6 
fermentation respectively, can be affected by the presence of pesticide residues in musts 7 
and wines (Cabras and Angioni, 2000). Nevertheless, while it has been shown that some 8 
wine yeasts are able to reduce the pesticide content, either by degradation or by 9 
adsorption (Cabras and Angioni, 2000), lactic acid bacteria do not posses this ability.  10 
Although maximum residue limits for most pesticides in wine have not been set, 11 
several countries have established guidelines for the correct use of pesticides and for the 12 
maximum residual limits for the treatment of vines and grapes used in winemaking 13 
(Flamini and Panighel, 2006). Because the vinification process decreases the levels of 14 
pesticides, their content in wines is significantly lower than in grapes. Therefore, 15 
methods to detect pesticide residues must be very precise and sensitive. Pesticides have 16 
been analyzed in wines mostly by gas chromatography (GC) (Jiménez et al., 2001, 17 
Hyötyläinen et al., 2004) and high-performance liquid chromatography (HPLC) (Nozal 18 
et al., 2005; Braga et al., 2007) and more recently,  by capillary electrophoresis (CE) 19 
(Molina-Mayo et al., 2006). Mass spectrometry represents an advantageous alternative 20 
for the simultaneous determination of different pesticides in wine. Recently, an 21 
interesting review about the applications of mass spectrometry for the determination of 22 
pesticides and other contaminants in grapes and wines has been reported (Flamini and 23 
Panighel, 2006).  24 
 7 
One aspect that deserves special attention is that phytosanitary treatments could 1 
be reduced if the plants own defence mechanisms come into play. Phytoalexins are 2 
antimicrobial compounds produced by plants, such as grapevine, in response to biotic 3 
and abiotic stress factors and have received a lot of attention over the last decade 4 
(Jeandet et al., 1997; Jeandet et al., 2002). These compounds can be released from 5 
plants as a response to infections by pathogens and hinder their development. They are 6 
often synthesized within a few hours after stress exposure.  They accumulate in the 7 
plant reaching a maximum content between 2 and 3 days after the induction. Therefore, 8 
stimulating the production of grapevine phytoalexins could be a strategy to limit the use 9 
of pesticides in vineyards. In the Vitaceae family, phytoalexins have been well 10 
characterized. They constitute a rather restricted group of molecules belonging to the 11 
stilbene family (for a review see Jeandet et al., 2002). Resveratrol (3,5,4’-12 
trihydroxystilbene) is the major phytoalexin produced in grapevine as a general 13 
response to different agents: fungal attack, leaf UV-C irradiation, heavy metal exposure, 14 
and ozone treatments. Other biosynthetically related compounds that have been found in 15 
grapevine as a result of stress conditions are viniferins and pterostilbene (3,5-16 
dimethoxy-4’-hydroxy stilbene) (Jeandet et al., 1997). A novel approach in the actual 17 
research on phytoalexins is the development of synthetic phytoalexins, similar to the 18 
natural ones, that can be used for plant disease control.  Stilbene phytoalexines are 19 
formed on the phenylalanine/polymalonate pathway and the last step in their 20 
biosynthesis is catalyzed by the enzyme stilbene synthase (STS) (Jeandet et al., 2002). 21 
Therefore, another valuable scientific strategy that is being performed is focused on the 22 
transfer of STS gene from grapevine to numerous plants, with the objective of 23 
increasing their tolerance to pathogenic microorganisms. Following this strategy, it has 24 
been possible to enhance the resistance of grapevine rootstock 41B to the infection of 25 
 8 
Botrytis cinerea. In addition to plants, the gene has been successfully transferred to 1 
yeast and mammalian cells (Zhang et al., 2006).   2 
 3 
Trace metal compounds  4 
 5 
 Although trace elements are essential for humans, many of them (e.g. As, Sb, Bi, 6 
Pb, Sn, Se, Te) have unknown biological function and are regarded as toxic because 7 
they accumulate in the human organism. In fact, at slightly higher levels than when 8 
found in living beings, they can have toxic effects (Baluja-Santos and Gonzalez Portal, 9 
1992).    10 
 It is well known that some trace elements play a relevant role in winemaking, for 11 
example Zn is essential at low concentrations, for the correct development of alcoholic 12 
fermentation, while Cu, Fe, and Mn have organoleptic effects at increased levels, 13 
contributing to the haze and taste of wines (Riganakos and Velssitas, 2003). Excessive 14 
amounts of iron (10-20 mg/L, or more) can cause stabilization problems in wines, since 15 
it may be oxidized to a ferric form causing precipitation of pigmented materials (‘Blue 16 
haze’) or with orthophosphate ions (‘White haze’).   17 
 Nevertheless, as Ajtony et al., (2008) have stated, the concern about human 18 
exposure to trace metals in beverages and  food products, including wines, has started to 19 
attract considerable  attention, since the consumption of wines, especially in fairly large 20 
volumes, may significantly contribute to the daily dietary trace element intake by 21 
humans. 22 
The primary natural mineral content of wines is determined by many factors such 23 
as type of soil, variety of grape, weather conditions, pollution and viticultural practices. 24 
In fact, the regionally varying trace metal content of wines can also be used for source 25 
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identification purposes (Pyrzynska, 2004). The secondary mineral contamination is 1 
derived from the use of pesticides and fertilizers or acquired during winemaking (in 2 
spite of the overall reduction in mineral content during this process) (Baluja-Santos and 3 
Gonzalez Portal, 1992). It has been shown for example, that while the origin of Cu in 4 
wines is associated with copper-based vineyard sprays, the content of As, Cd, and Pb 5 
reflects the differences in grape variety, environmental factors (e.g., soil, climate), and 6 
winemaking technology (Pyrzynska, 2004). 7 
 Sodium arsenite is employed in viticulture as fungicide against a grapevine 8 
necrotic disease known as Eutypa dieback, caused by the fungus Eutypa lata. Arsenic is 9 
a suspected carcinogen and little is known about its chronic sub-lethal effects. The 10 
concentration of As in wines mainly depends on factors such as soil composition, grape 11 
variety, climatic conditions, use of pesticides, winemaking technology and storage 12 
conditions (Flamini and Panighel, 2005).  The OIV has established the maximum limit 13 
of As in wine at 200 pg/µl, but in general, the presence of only a few pg/µl of As in 14 
uncontaminated wines is accepted (Baluja-Santos and Gonzalez Portal, 1992;  Pedersen 15 
et al., 1994;  Bruno et al., 1994).  16 
 In the case of lead, its presence in wine could be the consequence of the airbone 17 
particulate matter of atmosphere on grapes, and/or by the grapevine intakes from ground 18 
water and soil. The metal may also be released from bronze tanks, taps, pumps and 19 
tubing containers use in winemaking (Flamini and Panighel, 2005).  Lead adversely 20 
affects multiple enzyme systems of the body, as any ligand with sulfhydryl groups can 21 
be vulnerable. The best-known effect is that of the production of heme (Bornet and 22 
Teissedre, 2008) . Detection of lead in wine is usually focused on the determination of 23 
the total lead Pb
2+
. In wine the structurally complex pectic polysaccharide 24 
rhamnogalacturonan II (RG-II), an anionic biomolecule released from the grape during 25 
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winemaking, can form coordination complexes with specific cations such as lead 1 
(Flamini and Panighel, 2005). This pectic polysaccharide could reduce intestinal 2 
absorption and tissue retention of Pb as has been reported in rats, with a potential 3 
beneficial effect by minimising toxicity (Tahiri et al., 2000; Tairi et al., 2002). 4 
 The toxic effects of cadmium are due to the inactivation of enzymes containing 5 
sulphydryl groups and the uncoupling of oxidative phosphorylation in mitochondria. 6 
Cadmium may also compete with other metals such as zinc and selenium for inclusion 7 
into metallo-enzymes and it may compete with calcium for binding sites on regulatory 8 
proteins such as calmodulin (Bornet and Teissedre, 2008).  The OIV establishes the 9 
maximum concentrations of lead and cadmium in wine at 150 µg/L and 10 µg/L, 10 
respectively.  11 
 Taking into consideration the importance of these elements regarding their 12 
potential toxicity and technological features, it is worth noticing the great amount of 13 
scientific work that has been focused in developing adequate analytical tools that can 14 
offer enough selectivity, sensitivity and robustness for the analysis of these compounds 15 
in wines. As consequence, there are many analytical techniques for quantification trace 16 
metal in wines, such as ion chromatography (IC), stripping potentiometry, inductively 17 
coupled plasma mass spectrometry (ICP-MS), inductively coupled plasma atomic 18 
emission spectrometry (ICP-AES), flame atomic absorption spectrometry and graphite 19 
furnace atomic absorption spectrometry (GFAAS). All of them have been extensively 20 
reviewed elsewhere (Pyrzynska, 2004; Flamini and Panighel, 2006; Ajtony et al., 2008). 21 
 The multiple sources involved in the content of metal trace elements in wines 22 
make difficult the establishment of appropriate strategies to prevent or to avoid their 23 
occurrence in wines. Obviously, an adequate soil for each grape variety and 24 
environmental conditions, the regulation in the use of fertilisers, fungicides and others 25 
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pesticides or an adequate winemaking equipment could greatly reduce the amount of 1 
these elements in wines. Recently,  La Pera et al., (2008) in a study performed over two 2 
vintages (2003, 2004) have shown that treatments with the fungicides mancozeb, 3 
zoxamine and copper oxychloride significantly increased the levels of Mn, Zn, Cu, Pb 4 
and Cd of wines, grapes, marcs and grape stalks. 5 
 Some strategies that could be effective for the control of trace heavy metals 6 
imply the use of some polymers from natural sources. Chitin, chitosan and other 7 
derivatives are non-toxic biodegradable polymers that can remove metals and organic 8 
contaminants from food products (Bornet and Teissedre, 2005). Chitin exists widely in 9 
the cell walls of fungi, moulds and yeasts but also in the exoskeletons of some 10 
invertebrates such as molluscs, insects, etc. Chitosan is found only in a few species of 11 
fungi. Chitin and chitosan consist of 2-acetamido-2-deoxy-β-D-glucose and 2-amido-2-12 
deoxy- β-D-glucose as repeating units, respectively.  Bornet and Teissedre (2008) 13 
showed that the addition of chitosan, chitin, chitin-glucan and chitin-glucan hydrolysate 14 
of fungal origin (until 2 g/L) to wine, can reduce the amount of Fe by 32-91%, Cd by 15 
11-57% , and  Pb by  33-84 %, depending on the type of wine.  16 
 Furthermore, based on the parietal adsorption activity of yeasts (Caridi, 2007), 17 
the use of inactive yeast or yeast derivatives (walls, hulls, etc.) in wines, could also be 18 
considered in the future as a control mechanism for trace metal compounds to improve 19 
wine safety. 20 
 21 
 Sulphur dioxide 22 
 23 
One compound that should be considered in relation to the health quality of 24 
wines, is sulfur dioxide (SO2). Because of the abundance of sugars, nitrogen 25 
 12 
compounds, vitamins, mineral and salts, grape must is an ideal medium for microbial 1 
growth. SO2 has been used since the times of Romans for disinfection and cleaning of 2 
wine cellars. Although its use as preservative in wines has been known for centuries, it 3 
has been only recently, when its use in prefermentation operations during winemaking 4 
has been spreading out. Most of the scientific knowledge about the use of sulphur 5 
dioxide in oenology has been acquired over the last decades. In wines, this compound 6 
has multiple and diverse properties. For example, it is an antiseptic agent against yeasts 7 
and bacteria. The antioxidant properties, are well established since it consumes oxygen 8 
and acts against non-enzymatic and enzymatic oxidation of wines. Moreover it behaves 9 
as a solvent, activating the extraction from the solid parts of the grape, (skins, seeds, 10 
stems). Finally, since it favours the static settling of wines, it can be considering as a 11 
clarification agent. These and other properties, make this compound widely used during 12 
the different steps of winemaking and storage.  13 
 During winemaking, SO2 is mainly used on three occasions. Firstly, in the 14 
grapes or must during the prefermentation step, with the prime objective of preventing 15 
its oxidation; later, to inhibit microbial growth that can alter the wines, once the 16 
fermentation processes have finished and before the ageing or storage steps, and, 17 
finally,  just before bottling, to stabilise the wines and prevent any alteration or accident 18 
in the bottles.  19 
Today, the addition of SO2, is therefore, an essential treatment in winemaking 20 
technology. However, the use of this additive is strictly controlled, since high doses can 21 
cause organoleptic alterations in the final product (undesirable aromas from sulphurous 22 
gas or from the reduction products, hydrosulphate and mercaptanes) and, especially, 23 
owing to the risks for human health derived of its consumption.  24 
 13 
Various studies have revealed that besides their multiple properties, sulphites 1 
may induce relevant adverse effects after their ingestion (Taylor et al., 1986). Moreover, 2 
it has been shown that considerable percentage of consumers, show intolerance or high 3 
sensitivity to sulphites. This risk is higher for asthmatics and children. It is estimated 4 
that almost 1% of the population and 5% of the asthmatics are concerned. Although 5 
sulphites do not cause a true allergic reaction, sulphite-sensitive people may experience 6 
some similar responses. The symptoms may develop quickly and can include flushed 7 
face; rash, red and itchy skin; headaches; eye, face, lip or throat swelling; difficulty for 8 
breathing, speaking or swallowing; anxiety, distress, faintness, weakness; cramps, 9 
diarrhoea, vomiting, among others.  10 
The upper limit of sulfites permitted by the OIV ranges from 150 to 400 mg/l of 11 
total SO2, depending on the type of wine and its content in reducing matter. A first step 12 
to increase the food safety has been done by the EU through the approval of the 13 
legislation for regulation the use of sulphites as preservatives. Since then, directives 14 
2000/13/EC, 2003/89/EC and 2007/68/EC request the systematic labelling of allergens 15 
or similar (annexe III bis from directive 2000/13/EC) incorporated in food products. In 16 
the same way, since November 25
th
 of 2005, is mandatory to declare the presence of 17 
sulphites in wines and other foodstuffs when the concentration exceeds 10 mg/L or 10 18 
mg/kg. In addition, directives 95/2/EC and 2006/52/EC precise the maximum sulphite 19 
concentration allowed in different foodstuffs (included wine) within the EU.   20 
These legislative rules, together with consumer demands, have attracted the 21 
interest of scientific research on the study of other wine preservatives, harmless to 22 
health that can replace or reduce the amount of SO2 in wines. One example is the 23 
production of ‘ecological wines’, which in recent years have gained considerable 24 
interest. They are produced by environmentally friendly methods, from integrated or 25 
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sustainable manufacture methods. During the production of these wines, only a series of 1 
strict oenological practises are permitted and no additive apart from SO2 is possible. 2 
The final wine must have as low amount of sulphur dioxide as possible and must not, 3 
under any circumstance, exceed very strict limits (from 70 to 100 mg/l depending on the 4 
type of wine (EC Directive 2092/91). 5 
 Physical treatments, such as modified atmosphere packaging, control 6 
atmosphere storage, ozone, and other alternative non-conventional gas treatments have 7 
been applied to table grapes in order to prolong shelf life and storage, therefore reducing 8 
the SO2 doses necessary in the harvest (Artés-Hernández et al., 2003; Artés-Hernández 9 
et al., 2006).  10 
For wines, other methods for sulfites removal such as adsorption through the use 11 
of anion and cation exchangers (Brown, 1991) or the use of a membrane reactor in 12 
conjunction with non-diffusible oxidizing agents for sulfite oxidation (Seifter et al., 13 
1994) have been tested. Although both methods can reduce the sulfite content of wines 14 
below 10 ppm, the lack of selectivity in their adsorption mechanisms can greatly 15 
decrease important flavor compounds negatively affecting wine quality. Another 16 
original alternative for reducing sulfite contents in wine is the use of wheatgrass 17 
(Triticum aestivum) chloroplasts for the oxidation of sulfites to innocuous sulfates. It 18 
has been shown that a crude chloroplasts preparation at a concentration as low as 19 
5mg/mL, is able to reduce sulfites in commercial white wines from 150 ppm to 7.5 20 
ppm, as well as up to 93 % of the initial sulfite content in red wines within 45 minutes 21 
(Lin and Georgiou, 2004). Although this simple bio-catalytic process seems to be highly 22 
effective, inexpensive and largely valuable for the winemaking industry, appropriate 23 
sensory analysis would be necessary to evaluate the quality of these wines. 24 
 15 
 The effects of electrochemical treatments and pulsed electric fields on the 1 
growth and metabolism of wine yeast have been studied (Ranalli et al., 2002) and 2 
applied for controlling grape must fermentation in winemaking (Lustrato et al., 2003). 3 
These treatments could be an alternative to the use of SO2 since they are capable of 4 
destroying microorganisms and some enzymes while maintaining the characteristics of 5 
food products (Benicho et al., 2002). Nevertheless, more studies should be necessary to 6 
evaluate the potential use of these technologies in winemaking. 7 
Regarding other chemical alternatives to the use of sulphites, the use of 8 
dimethyldicarbonate (DMDC) has been recently described. This compound, also known 9 
as E242, can inhibit the development of spoilage and fermentative yeasts, allowing to 10 
reduce the dose of SO2 in some types of wines (Threlfall and Morris, 2002; Divol et al., 11 
2005). It also acts on bacteria and mould development, inactivating some vital enzymes 12 
for these microorganisms, therefore causing their death. DMDC is also currently used 13 
for cold sterilization of different types of drinks. 14 
Other alternatives focused on ‘natural antimicrobial agents’ have been developed 15 
to reduce the use of sulfite in wines. Among them, lysozyme (EC 3.2.1.17) has been 16 
recently introduced into the wine industry and offers important advantages for 17 
controlling malolactic fermentation in wine (Bartowsky, 2003; Pilatte, et al., 2000). 18 
Lysozyme (1,4- -N-acetylmuramidase)  has the ability to cleave the -1,4-glycosidic 19 
bonds present in Gram-positive bacteria. It has no effect on yeasts, is not affected by 20 
alcohol and is active in the pH range of the winemaking process. As an organoleptically 21 
neutral alternative, lysozyme can be beneficial to further reduce SO2 levels during 22 
winemaking. As wine pH increases, the antimicrobial activity of lysozyme increases as 23 
well, which makes it attractive for preventing spoilage in wines with high pH (Gao et 24 
al., 2002; Delfini et al., 2004). Despite lysozyme was firstly authorized as an additive in 25 
 16 
winemaking due to the high costs of its application, its use has been largely reduced. 1 
Another aspect that deserve consideration, is the IgE-mediated immune reactions that 2 
lysozyme can cause in some individuals (Mine and Zhang, 2002). Therefore its presence 3 
in food products, including wine, can cause some health concern.  4 
Currently, it is well known that other polypeptidic compounds, called 5 
bacteriocins, can also produce an inhibitory effect on the development of lactic acid 6 
bacteria. These products have received great attention in the manufacture of dairy 7 
products, since they are especially used as additives during cheese ripening (Martínez-8 
Cuesta et al., 2003). Because of the lack of effects of bacteriocins on wine organoleptic 9 
properties and the absence of toxic effects, some studies to evaluate their use in the 10 
control of malolactic fermentation during winemaking have been conducted (Navarro et 11 
al., 2000; Bauer et al., 2003, 2005). Generally, bacteriocins can be introduced into the 12 
wine by direct addition of the peptide (normally in its purified form), by adding a 13 
supernatant of a bacterial culture that contains a crude extract of the peptide, or by 14 
inoculation of a starter culture of lactic acid bacteria.  It has also been shown that after 15 
application of gene technology to transform laboratory strains of S. cerevisiae with the 16 
pediocin and leucocin structural genes, pedA and lcaB respectively, the transformed 17 
yeasts were able to produce biologically active bacteriocins, although in low levels 18 
(Schoeman et al., 1999). Despite the use of bacteriocins can be appropriate  for 19 
inhibiting the growth of spoilage bacteria in wines, up to date, nisin is the only 20 
bacteriocin that can be obtained commercially. Although it has been shown to be 21 
effective (Radler et al., 1990a,b; Rojo-Bezares et al., 2007), its use has not been 22 
authorized in winemaking.  23 
Another strategy that has been proposed to reduce the use of SO2 in oenology, is 24 
by using antimicrobial metabolites such as hydrogen peroxide (Du Toit et al., 2000). 25 
 17 
Glucose oxidase (GOX) from Aspergillus niger, which has GRAS status, is of 1 
considerable industrial importance. GOX metabolises glucose into gluconic acid and the 2 
antimicrobial compound that results from this conversion is hydrogen peroxide (H2O2). 3 
H2O2  has been shown to be active against both Gram-positive and Gram-negative 4 
bacteria. The gox gene was expressed in S. cerevisiae and the GOX-producing yeast 5 
transformant inhibited the growth of both acetic and lactic acid bacteria (Malherbe et 6 
al., 2003). 7 
 Currently there are increasing evidences of the potential application of some 8 
eukaryotic antimicrobial proteins and peptides as food preservatives
 
(Rydlo et al., 9 
2006). Among others, antimicrobial peptides derived from food proteins present clear 10 
advantages to be used in food preservation
 
(Pellegrini,  2003). Milk is a particularly 11 
interesting source of antimicrobial peptides that can be released after digestion with 12 
protease. Among them, lactoferrin (LF) is a multifunctional iron glycoprotein that 13 
exhibits a diverse range of biological effects, including antimicrobial, antiviral, 14 
antioxidant, and immunomodulatory activities (Tomita et al.,  2002).  Recently, its 15 
antimicrobial properties against phytopathogen molds has also been described (Muñoz 16 
and Marcos, 2006). Several strategies based on the use of hydrolizated LF have been 17 
also investigated to control microbial growth of Saccharomyces cerevisiae and other 18 
spoilage non Saccharomyces wine yeasts (Cryptococcus albidus, Dekkera bruxellensis, 19 
Pichia membranifaciens, Zygosaccharomyces bailii and Zygosaccharomyces bisporu) 20 
(Enrique et al., 2007).  Further studies would be required to gain more knowledge about 21 
the mode of action of these antimicrobial agents in wines and their consequences for 22 
wine quality. 23 
Recently, special attention has been paid to the potential of some natural 24 
constituents of grapes and wines, such as phenolic compounds, as an alternative to 25 
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sulphites (García-Ruiz, et al., 2008a).   It has been suggested that phenolic compounds 1 
can behave as activators or inhibitors of bacterial growth depending on their chemical 2 
structure (substitutions in the phenolic ring) and concentration (Reguant et al., 2000; 3 
Vivas et al., 1997). However, data are scarce since research has mainly been focused on 4 
studying the effect of hydroxycinnamic and hydroxybenzoic acids and some flavonols 5 
(Stead, 1993; Rozes and Peres, 1998; Campos et al., 2003; Alberto et al., 2001). In a 6 
recent study, the evaluation of the dual antioxidant and antibacterial activity of 21 7 
phenolic compounds mainly present in Vitis Vinifera L. belonging to different groups 8 
(hydroxybenzoic acids and their derivatives, hydroxycinnamic acids, phenolic alcohols 9 
and other related compounds, flavonols, anthocyanins and stilbenes) was examined 10 
(García-Ruiz et al. 2008b). Through the use of structure-activity relationships, the 11 
antimicrobial and antioxidant properties of some of these wine phenolics was 12 
demonstrated, confirming the potential use of these compounds as an alternative to 13 
sulphites in winemaking.  Nevertheless, more studies would be necessary to evaluate 14 
other phenolic structures present in wines and to elucidate the mechanism of action 15 
implicated on microbial inactivation.   16 
 17 
Compounds resulting from microbial metabolism  18 
 19 
Winemaking cannot take place without the action of microorganisms, mainly 20 
yeasts, and also lactic acid bacteria. Yeasts are essential to obtain wine, and lactic acid 21 
bacteria to make an important contribution to its organoleptic quality. However, the 22 
winemaking process includes multiple stages at which spoilage microoorganisms, 23 
mainly some strains and species of moulds, yeasts and lactic acid bacteria can develop 24 
and alter the quality and hygienic status of the wine, affecting the food safety for the 25 
 19 
consumers. Some interesting examples include the production of ochratoxin A, ethyl 1 
carbamate and biogenic amines, that will be discuss as follows. 2 
 3 
Ochratoxin A 4 
 5 
Ochratoxin A (OTA) is one of the most common naturally occurring 6 
mycotoxins, which is receiving increasing attention due to its toxic effects and high 7 
incidence in a wide range of food products. The IUPAC developed formula of OTA is 8 
1-phenylalanina-N-[(5-chloro-3,4-dihydro-8-hidroxy-3-methyl-1-oxo-1H-2-9 
benzopyran-7-yl)carbonyl]-isocoumarin (Ringot et al., 2006) (Figure 1). OTA is a 10 
mycotoxin considered to be a possible carcinogen (Class 2B) in humans (IARC, 1993) 11 
and it has been shown to be nephrotoxic, teratogenic, hepatotoxic and inmunotoxic in 12 
animals, and possibly in humans (Zimmerli and Dick, 1996). It has also been associated 13 
with the Balkan Endemic Nephropathy (BEN) and with the development of urinary tract 14 
tumors. Unfortunately, the presence of this compound in blood from healthy humans 15 
confirms a continuous and widespread exposure (Creppy, 2002).  16 
Since 1970 the occurrence of OTA in foods has been investigated and its 17 
presence has been confirmed in different food products such as cereals, coffee, some 18 
sauces such as soya sauce, cocoa, dried fruits, meat and beer (JECFA, 2001). In the 19 
European diet, wine and especially red wine, has been identified as the second major 20 
source of human exposure to OTA, following cereals. The occurrence of OTA in wine 21 
and grape has been reported in different countries, but higher levels of OTA were found 22 
in the southern regions of Europe than in northern regions (Zimmerli and Dick, 1996; 23 
Visconti et al., 1999; Otteneder and Majerus, 2000; López de Cerain et al., 2002; 24 
Bacaloni et al., 2005). Consequently, the European Commission has considered that is 25 
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necessary to impose regulatory limits establishing 2 g/L as the maximum level of OTA 1 
in wine and grape products (EC Nº 123/2005).  2 
OTA is produced by the secondary metabolism of several Aspergillus and 3 
Penicillium species, mainly by Aspergillus ochraceous and Penicillium verrucosum 4 
(Chulze et al., 2006). Recently, black Aspergillus species (section Nigri), including 5 
Aspergillus cabonarius, Aspergillus aculeatus and Aspergillus japonicus,  have been 6 
described as the main source for OTA contamination in grapes (Da Rocha Rosa et al. 7 
2002; Battiliani et al., 2003; Serra et al., 2003; Bellí et al., 2004; Leong et al., 2006a). 8 
Researchers agreed in considering A. carbonarius as the main causal agent of OTA 9 
presence in grapes in Europe and Israel (Battliani et al., 2006; Belli et al., 2006). 10 
Molecular methods (for an overview see Abarca et al., 2004) have led to an important 11 
progress in the identification of the fungi species responsible for OTA contamination in  12 
grapes and wine.  13 
Improvements in viticultural and winemaking practices are required to reduce 14 
OTA in wines. The great amount of work performed on this topic, has allowed to gain 15 
knowledge about the origin and mechanisms to explain the presence of OTA in wines 16 
and in the development of prevention and control strategies to avoid its occurrence. 17 
Recently with the aim to limit the presence of OTA in vine-derived products, the OIV 18 
has adopted a ‘Good Viticultural and Winemaking Practices Code’ based on 19 
recommendations and specific interventions for both harvest and cellars (OIV, 2005). 20 
The main measures considered by the OIV Code are summarized in Table 1.  21 
Factors affecting the presence of ochratoxin A in wines have been widely 22 
reviewed (Blesa et al., 2006; Mateo et al., 2007). Different practices in grape cultivation 23 
such as the type of cultivars, and in winemaking, including the storage conditions of the 24 
harvested grapes and the length of the storage, can influence the accumulation of 25 
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mycotoxins (Zimmerli and Dick, 1996). Some grape varieties may exhibit a greater 1 
susceptibility than others to Aspergillus bunch rots. However, once damage is set, there 2 
are no inherent differences in resistance to mould growth between different grape 3 
varieties. The substantial processing that grapes undergo during wine production is one 4 
of the major factors that influence OTA levels in wine (Leong et al., 2006b).  5 
Regarding preventive and corrective actions to reduce OTA content in wines, it 6 
should be taken into account that a good management of the vineyard guarantees a 7 
relevant decrease in OTA content at harvesting. A primary focus for continuing research 8 
in this subject is the development of vineyard management strategies to minimize the 9 
risk of OTA development in grapes and vineyard by reducing the incidence of black 10 
Aspergillus spp., in soils and grape brunches. One approach in this direction is the 11 
introduction of varieties that are more resistant to splitting and hence less susceptible to 12 
Aspergillus bunch rots. Further research should be conducted in order to examine the 13 
genetic relatedness of black Aspergillus isolates from various viticultural regions. 14 
Although additional OTA is not synthesised during winemaking, a careful management 15 
during wine production including corrective actions, would contribute to minimise OTA 16 
levels in wine. Data recently presented indicate that phenolic antioxidant compounds 17 
suppress OTA production in several important ochratoxigenic Aspergillus species 18 
(Palumbo et al., 2007). Whether searching for natural strategies for the reduction of 19 
OTA contaminations or the study of biosynthetic and regulatory genes involved in both 20 
OTA production and stress response in ochratoxigenic Aspergilli, can be useful tools for 21 
controlling OTA in wines. 22 
During both red and white winemaking, the removal of precipitated yeast cells 23 
and other sediments after fermentation results in further reductions in OTA content. 24 
Binding and precipitation of OTA may be enhanced through the addition of fining 25 
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agents. The influence of some oenological practices on OTA concentration in wine has 1 
been evaluated (Gambuti et al., 2005). Microfiltration (0.45 m) and the use of carbon 2 
are two useful treatments for wine decontamination, but the use of carbon results in the 3 
adsorption of several aroma compounds (Olivares-Marín et al., 2008). The feasibility of 4 
using selected adsorbents (bentonites, modified bentonites and chitosan) to reduce OTA 5 
levels in red wine has been recently investigated (Kurtbay et al., 2008). Quitine from 6 
yeast walls (2-acetamido-2-deoxi-B-D-glucose) has been shown to reduce OTA levels 7 
in wine (Bornet and Teissedre, 2008). In addition, yeast mannoproteins also play an 8 
important role for the removal of OTA because of their binding capacity (Bejaoui et al., 9 
2004). 10 
Subsequent operations during winemaking also reduce the OTA content of wine;  11 
This reduction has been shown to depend on several factors. In the case of red 12 
winemaking, the fermentation step reduces OTA content both in vitro and in true scale 13 
experiments; the efficacy of fermentations, both alcoholic and malolactic, in reducing 14 
OTA content is strictly dependent on the yeast and bacterial strains involved, and on the 15 
level of contamination (Mateo et al., 2007).  In white winemaking, OTA content always 16 
decreases and the rate of decrease depends on the choices for yeasts during alcoholic 17 
fermentation and on  the processing aids added for clarification.   18 
 19 
Ethyl carbamate 20 
 21 
Ethyl carbamate, also known as urethane, has been used as antiseptic for many 22 
years in the alcoholic drink industry. At the beginning of the Seventies, a scientific 23 
article reported for the first time that this compound could have potentially carcinogenic 24 
properties in laboratory animals when present at high concentrations (Canas et al., 25 
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1989). Since then, its use in food products is forbidden and considerable research 1 
regarding the mechanisms implicated in its formation in fermented and non-fermented 2 
foods, has gained interest. From the data obtained in experimental animals, it has been 3 
estimated that the daily dose for humans with no harmful effect is 0.3 ng/kg of body 4 
weight/day, which corresponds to 0.021 g/day for a person of approximately 70 kg.  5 
The formation of ethyl carbamate in wine is mainly attributed to the metabolism 6 
of the yeasts responsible for alcoholic fermentation. These microorganisms can 7 
sometimes produce a large amount of an intermediate metabolite, urea, that although in 8 
itself is not harmful to health, if the conditions are appropriate (high temperature, 9 
presence of ethanol and low pH), it can be transformed by a chemical reaction into ethyl 10 
carbamate during wine storage (Monteiro and  Bisson, 1991). But also, it has been 11 
demonstrated that during malolactic fermentation, lactic acid bacteria can produce other 12 
precursors of ethyl carbamate such as citruline and carbamyl phosphate, which, in the 13 
aforementioned conditions can result in the production of this compound (Liu et al., 14 
1995; Liu et al., 1996; Arena et al., 1999). In both cases, the initial substrate is arginine, 15 
one of the major amino acids present in grape must and wine (Lehtonen, 1996;   16 
Moreno-Arribas et al., 1998).  17 
The formation of ethyl carbamate by lactic acid bacteria, has probably been the 18 
line of research most followed in recent years in this field, especially in an attempt to 19 
reduce its concentration in wines. Certain wine-associated lactic acid bacteria have the 20 
ability to utilise arginine; these include strains of Oenococcus oeni and 21 
heterofermentative lactic acid bacteria, such as Lactobacillus brevis, L. buchneri, L. 22 
hilgardii. Homofermentative lactic acid bacteria (e.g. L. delbrueckii, L. plantarum) and 23 
pediococci do not catabolise arginine. Now, both, the enzymatic route involved (i.e. the 24 
arginine deiminase pathway) and the genes that encode the corresponding enzymes of  25 
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oenological lactic acid bacteria species are known  (Tonon et al., 2001). From the 1 
research performed, Mira de Orduña et al. (2001) concluded that the risk of citrulline 2 
formation by malolactic bacteria in wines with high residual arginine concentrations can 3 
be reduced by carrying out malolactic fermentation with pure oenococcal cultures and 4 
by precisely establishing complete malolactic conversion, which must be followed by 5 
inhibition of bacterial activity. Also, in this case, scientific results indicate the need for 6 
caution in the selection of starter cultures for MLF in wine, since citrulline formation 7 
from arginine degradation could result in ethyl carbamate production, even at normal 8 
temperatures, during prolonged storage. In addition, spontaneous malolactic 9 
fermentation by undefined strains should be avoided, as this may lead to formation of 10 
ethyl carbamate precursors. 11 
Nowadays vine growers and winemakers have sufficient knowledge to prevent 12 
or reduce the formation of ethyl carbamate during the production process. The strategies 13 
for controlling the presence of this compound in wines are focused on the three factors 14 
involved in its production: vine growing and wine production practises that could 15 
increase the concentration of arginine in the grape; to control the winemaking process, 16 
especially the alcoholic and malolactic fermentations, and finally, the ageing and 17 
maturation of the wine. On the other hand, legislation authorises the use of an 18 
enological additive, the enzyme urease, in wines with high urea levels. The urease used 19 
is isolated from Lactobacillus fermentum. This enzyme has been effective on urea at 20 
doses of 50 mg/L in red wines and at doses of 25 mg/L in white wines (Bertrand, 1997). 21 
A systematic study carried out to examine the ethyl carbamate levels of Spanish 22 
red wines from different grape varieties (Uthurry et al., 2004), showed that typical 23 
Spanish red wines had concentrations of ethyl carbamate below 30 ppb. During the 24 
alcoholic fermentation of the corresponding musts no ethyl carbamate was formed, even 25 
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in the presence of nitrogenous substrates, and low concentrations were recorded (≤ 1.3 1 
ppb). Generally, regarding urea levels founded at the end of the alcoholic fermentation 2 
it was concluded that small quantities of ethyl carbamate would be formed under the 3 
normal storage conditions of wines (Uthurry et al., 2007) .  4 
 5 
Biogenic amines 6 
 7 
Amines are widely occurring compounds in nature, containing one or more 8 
organic substituent bonded to a nitrogen atom. Biogenic amines are low molecular 9 
weight compounds, derived from aromatic or cationic amino acids and all of them have 10 
one or more positive charge and a hydrophobic skeleton. Depending on their chemical 11 
structure they can be classified in aliphatic (putrescine, cadaverine, spermine, 12 
spermidine), aromatic (tyramine, phenylethylamine) or heterocyclic (histamine, 13 
tryptamine) (Figure 2). They are endogenous of plants but can also be found in fresh 14 
fruit and vegetables. However, amines are mainly formed in foods by fermentative 15 
processes and during ageing and storage. Recently, knowledge concerning the presence 16 
of amines in wines has been reviewed (Ferreira and Pinho, 2006; Ancín-Azpilicueta et 17 
al., 2008). 18 
Problems related to biogenic amine formation affect numerous fermented food 19 
products consumed more frequently than wine, such as cheese, beer, some fermented 20 
sausages and meat products among others (Fernándes-García et al., 1999; Izquierdo-21 
Pulido et al., 2000; Kaniou et al., 2001), which have higher levels of these compounds. 22 
However, in alcoholic drinks, especially in wine, biogenic amines have received more 23 
attention, because ethanol and acetaldehyde can increase their effects on health by 24 
directly or indirectly inhibiting the enzymes responsible for the detoxification of these 25 
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compounds in the intestinal tract (Maynard and Schenker, 1996).  Although there are 1 
differences in individual susceptibility to intoxication by biogenic amines, several 2 
pharmacological reactions can take place after excess intake of these compounds. The 3 
most well-known reactions are those caused by histamine. More specifically, some 4 
histamine–induced symptoms include rash, edema, headaches, hypotension, vomiting, 5 
palpitations, diarrhoea and heart problems. Other amines, such as tyramine and 6 
phenylethylamine, can cause hypertension and other symptoms associated with 7 
vasoconstriction due to the release of noradrenaline (especially cerebral haemorrhages 8 
and migraine). Although putrescine and cadaverine are not themselves toxic, they can 9 
increase the toxicity of histamine, tyramine and phenylethylamine, since they interfere 10 
in detoxification reactions.  11 
Some polyamines, such as putrescine, may already be present in grape berries 12 
(Halász et al., 1994; Bover-Cid et al., 2006; Del Prete et al., 2008) or be produced 13 
during fermentation processes, ageing or storage, when wine is exposed to the 14 
undesirable activity of decarboxylase-positive microorganisms. Contamination may also 15 
occur from poorly sanitary conditions of both grapes and processing equipment. 16 
Although yeasts may also contribute to the final levels of biogenic amines in wines 17 
(Torrea and Ancín, 2002; Caruso et al., 2002), most biogenic amine contamination of 18 
wine is believed to take place during malolactic fermentation from the presence of lactic 19 
acid bacteria strains that produce enzymes which decarboxylate the corresponding 20 
precursor amino acids (Marcobal et al., 2006a).  For example, in the production of the 21 
biogenic amine histamine, the enzyme involved is histidine decarboxylase, which acts 22 
on the amino acid precursor, histidine.  23 
It is well known that among the species and strains of wine’s lactic acid bacteria, 24 
some of them are practically unable to produce biogenic amines whereas others are 25 
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characterized for their high capacity of production. It is often to detect aminobiogenic 1 
strains among heterofermentative lactobacilli (Lactobacillus hilgardii y L. brevis) 2 
(Moreno-Arribas et al., 2000), although among histamine producers strains, some 3 
Pediococcus (Landete et al., 2005;  Bodmer and Gafner, 2000) and O. oeni strains have 4 
been also isolated (Coton et al., 1998). The latter have also been found to be a 5 
putrescine producer (Marcobal et al., 2004; Marcobal et al., 2006b). Although it has 6 
been demonstrated that oenococci could produce histamine and putrescine, this property 7 
seems to be variable and is only present in some strains, which explains why in other 8 
studies, strains of biogenic amine-producing O. oeni have not been found (Constantini 9 
et al., 2006; Moreno-Arribas  and Polo, 2008).   10 
Molecular methods for the detection of biogenic amine-producing bacteria have 11 
been recently reviewed by Landete et al., (2007). PCR techniques have been developed 12 
to detect bacterial amino acid decarboxylases in a rapid, sensitive and accurate way. 13 
They cannot determine quantitative (or qualitative) amounts of biogenic amines, but can 14 
be used to estimate the potential risk for amine formation. Multiple PCR systems that 15 
use different pairs of primers to simultaneously detect lactic acid bacteria producers of 16 
histamine, tyramine and putrescine, the major wine biogenic amines have been 17 
developed (Marcobal et al., 2005b; Constantini et al., 2006). This system detects the 18 
presence of genes that encode the enzymes responsible for synthesizing these amines in 19 
bacteria. Quantitative PCR (or real time PCR) allows knowing the number of potential 20 
amine producers bacteria in wine, therefore it is an interesting tool to evaluate the risk 21 
for biogenic amine production from a specific bacteria population (Lucas et al., 2008). 22 
 From the wide range of techniques described in the literature to determine the 23 
concentration of biogenic amines in wines, reverse phase high-performance liquid 24 
chromatography (RP-HPLC) is one of most used in laboratories, since it is possible to 25 
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obtain valuable information about the presence and concentration of amines in musts 1 
and wines (Lehtonen, 1996;  Torrea and Ancín, 2002; Marcobal et al., 2005a; Gómez-2 
Alonso et al., 2007). Moreover, other chromatographic techniques applicable to 3 
biogenic amine analysis, such as micellar liquid chromatography (MLC) (Gil-Augustí et 4 
al., 2007) and liquid-chromatography-electrospray ionisation ion trap mass 5 
spectrometry  (Millán et al., 2007) have been developed. Enzymatic methods (ELISA or 6 
other enzymatic tools) for histamine analysis able to determine levels of this amine in a 7 
short time and do not require sophisticated equipment have lately appeared (Marcobal et 8 
al., 2005). In recent years there has also been a growing interest in the use of capillary 9 
electrophoresis (CE) and different CE methods with diverse detection systems (Santos 10 
et al., 2004; Simó et al., 2008).  11 
Regarding enological practices and technological factors that may influence 12 
biogenic amine formation in wines, special attention should be paid to some oenological 13 
practices frequently used to enhance wine complexity (flavour and aroma), but that also 14 
can increase the concentration of the precursor amino acids, such as the ageing of wines 15 
with lees or longer maceration times (Martín-Álvarez et al., 2006).  Yeasts can 16 
indirectly play an important role on the production of biogenic amines by lactic acid 17 
bacteria, since they affect the amino acid composition during the alcoholic fermentation  18 
(Soufleros et al., 1998) or during autolysis (Moreno-Arribas et al., 1998; Villamiel et 19 
al., 2008). These amino acids can act as precursor for the formation of biogenic amines 20 
during malolactic fermentation and during wine ageing (Martín-Álvarez et al., 2006; 21 
Marques et al., 2008). Yeast and bacteria lees can also be a source for decarboxylase 22 
enzymes that could be involved in amine production (Marcobal et al., 2004). 23 
The use of bacteria starter with specific characteristics such a very reduced or 24 
null capacity to produce biogenic amines, is the most popular strategy to control amine 25 
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production during winemaking. O. oeni commercial starters are selected on the basis of 1 
their oenological properties and among them, the absence of amino acid decarboxylase 2 
enzymes is an important requirement. Research performed in in vitro studies (Moreno-3 
Arribas et al., 2003) and in industrial conditions during winemaking (Marcobal et al., 4 
2006a) have shown the viability of using bacteria starters without the gene involved in 5 
biogenic amine production to prevent the formation of amines in wines. Moreover, it 6 
has been shown that the co-inoculation of O. oeni starters simultaneously to the 7 
alcoholic fermentation as opposite to the conventional  inoculation once the alcoholic 8 
fermentation has been completed, is more effective to avoid the production of biogenic 9 
amines (Smit, 2007).  10 
The use of different clarification substances and oenological adjuvants, such as 11 
bentonite PVPP at the normal dose used in winemaking can affect the concentration of 12 
biogenic amines in wines, since these compounds have the ability for the adsorption of 13 
some of them (Alcaide-Hidalgo et al., 2008). Also the type container employed during 14 
malolactic fermentation (stainless steel or oak barrel) seems to affect biogenic amine 15 
content of wines (Alcaide-Hidalgo et al., 2007a). Some alternative techniques for wine 16 
ageing based on the use of wood chips or oenological tannins, can also influence the 17 
amine production depending on the product type and on the dose of these compounds 18 
applied to the wines (García-Ruiz et al., 2008b).   19 
Biogenic amine formation is also determined by wine parameters, such as pH, 20 
ethanol and SO2, which have an important effect on the diversity of microorganisms, 21 
decarboxylase enzyme activity and decarboxylase gene expression (Lonvaud-Funel, 22 




COMPOUNDS PRESENT IN WINE WITH POTENTIALLY BENEFICIAL 1 
EFFECTS ON HEALTH 2 
 3 
Since the postulation of the French paradox in 1992 by Renaud and de Lorgeril 4 
(1992), moderate consumption of red wine has been associated with reduce risk of 5 
developing cardiovascular heart disease (CHD). The findings that constitute the French 6 
paradox for CHD were confirmed in the MONICA project, a worldwide study for 7 
cardiovascular diseases organized by the World Health Organization, that showed that 8 
the mortality rate from CHD was much lower in France, than in other industrialised 9 
countries such as USA and UK, despite the presence of high level of risk factors, such 10 
as cholesterol, diabetes, hypertension, and high intake of saturated fat. These effects 11 
were partly attributed to the high intake of wine and in general to the so-called 12 
Mediterranean-type diet, which is particularly abundant in fruits, vegetables and olive 13 
oil. These findings were already in agreement with a previous epidemiological study 14 
reporting an inverse association between moderate wine consumption and CHD (St 15 
leger et al., 1979). Later studies have also confirmed the results of Renaud et al. (1992). 16 
Gronbaek et al. (2000) found that all-cause mortality was reduced in wine but not in 17 
non-wine drinkers in a study including 24,523 subjects over 10 years.  In a meta-18 
analysis on 209,523 subjects, di Castelnuovo et al. (2002) also reported a larger benefit 19 
for wine ( 22% reduction) than for beer. Wine drinkers were found to have a lower 20 
mortality risk than beer o liquor drinkers in a follow-up study including 128,934 21 
subjects up to 20 years (Klatsky et al., 2003). The better effects of wine in comparison 22 
to other alcoholic beverages have been mainly attributed to the presence of antioxidant 23 
polyphenols that provide additional benefits. Other compounds such as low-molecular-24 
weight peptides exhibiting antihypertensive activity could also contribute to these 25 
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beneficial effects. However, other prospective studies have indicated that the beneficial 1 
effects of alcohol intake were not dependent on the type of alcoholic beverage 2 
(Mukamal et al., 2003, Imhof et al., 2004). In a meta-analysis, moderate alcohol 3 
consumption (as much as 30 g alcohol/day) was related to lower risk (20-45% 4 
reduction) of CHD compared with abstention (Rimm et al., 1999). Discrepancies among 5 
studies have been attributed to the existence of many confounding variables related to 6 
life style and genetic factors. Health effects of moderate alcohol consumption (  2 7 
drinks/day) have been mainly related to an increase in HDL-cholesterol as well as to 8 
other protective mechanisms such as anti-platelet, anti-coagulatory, and anti-9 
inflammatory effects (Rimm et al., 1999, Imhof et al., 2004). However, three or more 10 
drinks per day are associated with cardiomyopathy, hypertension, hypertriglyceridemia, 11 
and stroke. Although keeping in mind the importance of alcohol in the potentially 12 
beneficial effects of wine on human health, our dissertation will be focus on phenolic 13 
compounds and peptides as specific wine components with potentially beneficial 14 
effects. 15 
 16 
Phenolic compounds 17 
 18 
The term "phenolic" or "polyphenolic" describes the compounds that possess a 19 
benzenic ring substituted by one or several hydroxyl groups (-OH). Based on their 20 
carbon skeleton, polyphenols are classified in non-flavonoid and flavonoid compounds. 21 
Main non-flavonoid compounds present in wine are phenolic acids (hydroxybenzoic 22 
and hydroxycinnamic acids), as well as others phenolic derivatives such as stilbenes 23 
(Figure 3). Flavonoid compounds present in wine mainly include the flavonols, flavan-24 
3-ols and anthocyanins, as well as flavanonols and flavones, in lower proportion 25 
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(Figure 3). Due to their chemical structure, containing several hydroxyl groups, 1 
stilbenes and flavonoids have been demonstrated to be the most bioactive compounds in 2 
wine.  3 
 Hydroxylated stilbenes, as previously decribed in section #, are phytoalexins 4 
synthesized by the plant, especially in the skins, leaves and roots, in response to fungal 5 
infections and ultraviolet (UV) light (Jeandet et al., 1991; Korhammer et al., 1995). 6 
Stilbenes present in wine include trans and cis resveratrol (3,5,4'-trihydroxystilbene), as 7 
well as their glucose derivatives (trans and cis piceid). A series of mono-, di-, and 8 
tetrahydroxystilbenes have been also identified in wine (Lamikanra et al. 1996; Ribeiro 9 
de Lima et al. 1999; Baderschneider and Winterhalter, 2000). Considering that grapes 10 
and their derived products are the most important dietary sources of stilbenes (Mattivi et 11 
al., 1995), resveratrol metabolites have been recently proposed as a biomarkers of 12 
moderate wine consumption in humans (Zamora-Ros et al., 2006). 13 
 In relation to the flavonoid phenolic compounds found in wine, flavonols are 14 
yellow pigments mainly located in the vacuoles of the epidermal tissues.  In wine they 15 
exist as the 3-O-glycosides of four main aglycones: myricetin, quercetin, kaempherol 16 
and isorhamnetin (Figure 3). Flavan-3-ols or flavanols are found in wine in monomeric, 17 
oligomeric or polymeric forms in the solid parts of the grape; the latter two forms are 18 
also known as proanthocyanidins or condensed tannins. Flavanol monomeric units 19 
include (+)-catechin, (-)-epicatechin, (-)-epicatechin-3-O-gallate, (+)-gallocatechin and 20 
(-)-epigallocatechin (Figure 3). Proanthocyanidins are constituted of flavanols units 21 
linked by C4-C6 or C4-C8 bonds. Proanthocyanidins with a mean degree of 22 
polymerization between 3 and 7 units have been reported in red wine (Fulcrand et al., 23 
1999). Anthocyanins are pigment located in the grape skins of red grape varieties. Main 24 
anthocyanins identified in wine include the 3-O-monoglucosides and the 3-O-acylated 25 
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monoglucosides of five main anthocyanidins: delphinidin, cyanidin, petunidin, peonidin 1 
and malvidin (Figure 3). These compounds could be acylated in the C-6 position of the 2 
glucose molecule by esterification with acetic, p-coumaric and caffeic acids. Both, 3 
anthocyanins and flavanols are the most abundant flavonoids in red wines and they are 4 
largely responsible for the color, bitterness, astringency and chemical stability of red 5 
wines. A glass of red wine provides approximately 100 mg of polyphenols. In 6 
comparison to red wines, white wines are devoid of anthocyanins, and due to absence of 7 
skins and seed contact during maceration and fermentation in white wine technology, 8 
they possess a lower content of phenolic compounds, in particular of flavonoids. 9 
 In vitro and animal model studies have demonstrated that red wine polyphenols 10 
are protective agents against the development and progression of atherosclerosis 11 
(Dell’Agli et al., 2004). This protection is related to: i) inhibition of LDL oxidation 12 
(Frankel et al., 1993; Lourenço et al., 2008); ii) vasorelaxation (reduction of blood 13 
pressure; endothelium-dependent vasorelaxation by increased generation of NO, 14 
endothelium-derived hyperpolarizing factor and prostacyclin, or by reduction of the 15 
vasoconstrictor endothelin-1) (Fitzpatrick et al., 2000; Diebolt et al., 2001; Ndiaye et 16 
al., 2003, Schramm et al., 1997; Corder et al., 2001); iii) inhibition of vascular smooth 17 
muscle cell migration and proliferation [by possible inhibiting platelet-derived growth 18 
factor (PDGF) β-receptor and vascular endothelial growth factor (VEGF)] (Rosenkranz 19 
et al., 2002; Ferrera et al., 1999); and iv) inhibition of platelet aggregation (by 20 
stimulation of the synthesis of prostacyclin; suppression of platelet activation response 21 
to epinephrine; increase of platelet c-AMP levels) (Gryglewski et al., 1987; Rein et al., 22 
2000; Russo et al., 2001). Administration of red wine, dealcoholized wine or grape juice 23 
has also been shown to attenuate the development of atherosclerotic lessions (da Luz., 24 
1999; Vinson et al., 2001) and to prevent thrombosis (Demrow et al., 1995) in 25 
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experimental animals. Red wine polyphenols also exhibit antiviral (Takechi et al., 1 
1985), antibacterial (Cueva et al., 2008), anticancer (Franke et al., 2002; Weyant et al., 2 
2001) and antiulcer (Saito et al., 1998) activities. Finally, the implication of red wine 3 
polyphenols in the modulation of gene expression has also been reported (Sen and 4 
Bagchi, 2001).   5 
 6 
 The health effects observed in in vitro and animal model studies have been 7 
partially confirmed in human subjects. A summary of short-term human intervention 8 
studies related to wine polyphenols is presented in Table 2. These studies have focused 9 
on confirming the hypothesis that: i) red wine provides more beneficial effects than 10 
other alcoholic beverage (red wine vs. spirits or beer); ii) red wine properties are beyond 11 
alcohol (red wine vs dealcoholized wine or grape juice); iii) red wine leads to greater 12 
beneficial effects than white wine, and iv) polyphenols are responsible for red wine 13 
properties. Most studies have been conducted on healthy men only, or on healthy men 14 
and women, with the exception of one study that was performed on healthy women 15 
(Sacanella et al., 2007). Intervention periods ranged between 14 and 30 days, although 16 
some acute intake (1 day) studies have also been performed. Alcohol doses were on the 17 
order of 20-40 g ethanol/day.  Biomarkers significantly affected in these trials are 18 
related to red wine: i) antioxidant effect (inhibition of the LDL oxidation; reduction of 19 
plasma lipid peroxides, thiobarbituric acid-reactive substances, conjugated dienes, and 20 
urine isoprotanes levels; increase  in plasma  antioxidant capacity, plasma polyphenol 21 
content and LDL polyphenols); ii) effects on lipid metabolism (increment in plasma 22 
HDL cholesterol; reduction of LDL/HDL ratio and LDLox antibody); iii) anti-23 
thrombotic effects (reduction of trombine-induced and collagen-induced platelet 24 
aggregation; reduction of plasmatic levels of tromboxane B2, fribinogen, factor VII, t-25 
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PA, PAI);   iv) effects on vascular function (reduction in flow-mediated dilatation of the 1 
brachial artery), and vi) anti-inflammatory effects (reduction of the expression of  2 
adhesion molecules on monocyte surface, including LFA-1, Mac-1, VLA-4 andMCP-1; 3 
reduction of serum levels of hs-CRP, VCAM-1, ICAM-1 and E-selectin; increment of 4 
TGFβ1). The anti-inflammatory effects of white sparkling wine (cava) in comparison to 5 
gin have also been determined and were on favour of cava (Vázquez-Agell et al., 2007). 6 
However, it is important to highlight that the other studies failed to find positive 7 
outcomes for some parameters after red wine consumption. According to Djoussé et al. 8 
(1999), no significant changes were found in flow-mediated dilation of the brachial 9 
artery when red wine was drunk together with a fatty meal. Watzl et al. (2002, 2004) did 10 
not find changes in anti-inflammatory biomarkers after acute and chronic consumption 11 
of red wine.  Van deer Gaag et al. (2000a,b) found an increase in plasma homocysteine 12 
levels after red wine consumption and no significant changes in the activity of 13 
antioxidant enzymes or plasmatic levels of some antioxidant vitamins.  14 
 The in vivo physiological importance derived from wine consumption is 15 
dependent on the bioavailability (absorption, distribution, metabolism and excretion) of 16 
wine polyphenols. The metabolic pathway of polyphenols is well established (Scalbert 17 
and Williamson, 2000). The bioavailability of wine polyphenols is influenced by their 18 
chemical structure. Monomers and dimeric procyanidins in a lower extent, are directly 19 
absorbed in the small intestine, whereas oligomers with a mean degree of polimerization 20 
(mDP)>3 and polymeric flavanols  (proanthocyanidins) are not absorbed in their native 21 
forms or degraded under the acidic conditions of the stomach in vivo (Rios et al., 2002). 22 
These compounds reach the colon where they are metabolized by the intestinal 23 
microbiota into various phenolic acids, including phenylpropionic, phenylacetic and 24 
benzoic acid derivatives that can be further absorbed by enterohepatic recirculation via 25 
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the bile duct (Manach et al., 2004). In the other hand, glycosilated polyphenols such as 1 
resveratrol glucosides and anthocyanins, must be first hydrolyzed by intestinal β-2 
glucosidases before they can be absorbed (Manach et al., 2004). However, in the case of 3 
wine anthocyanins, it has been demonstrated that they can be absorbed in their 4 
glycosilated form after oral ingestion (Matsumoto et al., 2001; Cao et al., 2001; McGhie 5 
et al., 2003). 6 
 After passing across the small intestine brush border, polyphenols are 7 
extensively conjugated first in the small intestine and then in the liver into methyl, 8 
glucoronide and sulphate derivatives by the enzymes catechol-O-methyltransferase, 9 
UDP-glucuronosyl transferase, and phenol sulfotransferases, respectively (Scalbert and 10 
Williamson, 2000). In general, glucuronide metabolites are the most abundant 11 
metabolites in plasma and only trace amounts of native forms are found. However, in 12 
the case of anthocyanins, although the existence of methyl, glucuronide and sulfate 13 
derivatives has been demonstrated (Wu et al., 2002; Felgines et al. 2003), intact 14 
glycosides were the only metabolites reported in previous studies, probably due to their 15 
degradation during sample conservation (Manach et al., 2004). This fact together with 16 
other issues related to the use of inappropriate analytical methods may have resulted in 17 
an underestimation of anthocyanin bioavailability in early studies. 18 
 Pharmacokinetic studies indicate that after the ingestion of 35 mg of catechin 19 
supplied in the form of red wine (120 mL), the maximum concentration (Cmax) of 20 
catechin in plasma was on the order of 0.077-0.091 mol/L, and was achieved at a mean 21 
time (Tmax) between 1.44-1.50 h.  Urinary excretion ranged between 3-10% of the intake 22 
and the elimination half-life was approximately 3 h (Donovan et al., 1999, 2002; Bell et 23 
al., 2000). Concerning proanthocyanins, up to date there is no literature data of the 24 
absorption of these compounds after wine consumption. A plasma concentration of 25 
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0.0011 mol/L of procyanidin B1 has been reported after the ingestion of grape seed 1 
extract (18 mg of procyanidin B1) in humans (Sano et al., 2003). In relation to the 2 
microbial metabolism of proanthocyanins into phenolic acids, Gonthier et al. (2003) 3 
have shown that the DP has an inverse association with the extent of microbial 4 
degradation in rats fed purified monomeric, dimeric, trimeric or polymeric flavanols. In 5 
comparison with flavanols, anthocyanins are more rapidly absorbed. After the ingestion 6 
of 68 mg of malvidin-3-glucosides in the form of red wine (500 mL), Tmax in plasma 7 
and urine was attained at 0.83h and <3h, respectively (Bub et al., 2001); data which 8 
seem to be consistent with absorption in the stomach. However the Cmax was much 9 
lower (1.4 nmol/L) than for flavanols, as well as the urinary excretion (0.016%) (Bub et 10 
al., 2001).  In another study, higher urinary excretion were found (1.5-5.1 %) after the 11 
consumption of 300 mL red wine (218 mg of total anthocyanins) (Lapidot et al., 1998). 12 
The bioavailability of resveratrol has not been determined after the consumption of red 13 
wine in humans. Oral administration of resveratrol (0.026 mg total resveratrol) to rats in 14 
the form of wine (4 mL), gave resveratrol levels of 0.1 mol/L, which is similar to that 15 
of catechin (Bertelli et al., 1996).  A larger number of studies should be carried out in 16 
order to acquire more information about the metabolism of red wine polyphenols after 17 
acute or chronic consumption of wine and its correlatation with the observed in vivo 18 
effects. 19 
 20 
Peptides  21 
 Peptides are important wine compounds involved in different properties, such as 22 
tensioactive (González-Llano et al., 2004), sensorial (Desportes et al., 2001) or functional 23 
(Pozo-Bayón et al., 2007) properties. In addition, they can act as yeasts and bacteria 24 
nutrients (Feuillat et al., 1977; Alexandre et al., 2001; Manca de Nadra et al., 2005; 25 
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Remize et al., 2006). However, wine peptides are the least known nitrogen compounds. 1 
The main reason for the dearth of studies on this fraction is due to their complexity and 2 
lack of specificity of the techniques used for their analysis.  3 
Due to the wide range of structures (amino acid composition and sequence) in 4 
which these compounds may appear, peptides form a heterogeneous group of 5 
compounds. Generally speaking, the term oligopeptides, or low-molecular-weight 6 
peptides, refers to peptides with 10 or fewer residues of amino acids, while the term 7 
polypeptides is used for peptides with more amino acids. Although the transition point 8 
from polypeptide to protein is not well defined, proteins are normally considered to 9 
have at least 100 residues of amino acids (Mr> 10,000). 10 
 In recent years, several studies have focused on their origin and identification 11 
(Acedo et al. 1994; Moreno-Arribas et al. 1998) and in some cases,  the sequence of 12 
amino acids have also been elucidated (Yahai et al. 2003; Person et al. 2004; Desportes 13 
et al. 2001). Some of these studies have shown that the amino acids aspartic acid and/or 14 
asparagine and glutamic acid and/or glutamine are involved in the majority of wine 15 
peptides, independently of the type of wine or the analytical methodology employed in 16 
the analysis.  17 
 The wine peptide fraction is continuously changing both qualitatively and 18 
quantitatively. Some wine peptides come from the must, but most of them appear in the 19 
different stages of wine production. During alcoholic fermentation, especially if it takes 20 
place in nitrogen-deficient media, there is a reduction in their concentration. In the final 21 
stages of fermentation, peptides are released into the medium, reaching the maximum 22 
concentration after cell death (Usseglio-Tomasset and Bossia, 1990). In fact, it has been 23 
shown that, at least part of the peptide fraction of wines is derived from the yeasts 24 
involved in the alcoholic fermentation. These peptides can be hydrolysed by the action 25 
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of extracellular enzymes, being transformed into low molecular weight peptides 1 
(Moreno-Arribas et al., 1996; Martínez-Rodríguez et al., 2000, 2001). The existence of 2 
endo and exocellular proteases has been evidenced under winemaking conditions 3 
(Feuillat et al., 1980; Alexandre et al., 2001). This process is even more important in 4 
winemaking technologies based on ageing the wines with yeasts for long periods of 5 
time, such as biologically aged wines (Dos Santos et al., 2000; Villamiel et al., 2008) 6 
and sparkling wines manufactured by the traditional method (Moreno-Arribas et al., 7 
1996, 1998 a,b). 8 
 Also, some wine lactic acid bacteria strains have shown proteolytic activity 9 
under winemaking conditions (Feuillat et al., 1980; Manca de Nadra et al., 1997; Leitào 10 
et al., 2000). This activity has been found even in the presence of ethanol and SO2 11 
(Manca de Nadra et al., 2005) and has been reported to be greater in red than in white 12 
wines (Manca de Nadra et al., 1999). The proteolytic activity is a very important 13 
characteristic for some bacteria strains allowing them to growth in nitrogen-deficient 14 
media, and  to carry out the malolactic fermentation. According to Remize et al. (2005) 15 
and Remize et al., (2006), peptides from 0.5 to 10 kDa seem to be more favourable for 16 
the growth of wine lactic acid bacteria than other nitrogen sources (<0.5 kDa). Alcaide-17 
Hidalgo et al., (2008) have observed a reduction in peptides during the malolactic 18 
fermentation of red wines followed by an increase during the ageing in barrels, that was 19 
more pronounce when the aging was in presence of lees. The occurrence of proteolytic 20 
activity in all the stages of wine manufacture may be responsible for the wide range of 21 
peptides that can be present in a wine at any time, and the discrepancies in most of the 22 
studies related to their identification. 23 
 Low molecular weight peptides can be implicated in important biological 24 
activities such antimicrobial and antioxidant. The antihypertensive activity is the 25 
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bioactive property of peptides that has been most studied . The increase in hypertension 1 
rates of the population in recent years, which is considered as one of the commonest 2 
chronic diseases in developed countries, has favoured these types of studies.  Most of 3 
the antihypertensive peptides derived from foods act by inhibiting angiotensin-4 
converting enzyme (ACE). In the organism, ACE is present in a large number of organs 5 
and tissues, such as lung, intestine, kidneys, testicles, heart, skeletal muscle, pancreas, 6 
spleen or placenta. It is thought that the ACE located in the lung belongs to the renin-7 
angiotensin system, one of the main mechanisms that regulates blood pressure in the 8 
body. The mechanism of action of the enzyme operates at two levels, on one hand, it 9 
catalyses the transformation of angiotensin I to angiotensin II, which has a strong 10 
vasoconstrictor action in the sympathic nervous system and on the blood vessels. One 11 
the other hand, ACE inactivates bradykinin, a strong vasodilator and natriuretic. Both 12 
mechanisms cause an overall increase in blood pressure. The use of ACE inhibitors as 13 
active ingredients is the strategy of current antihypertensive drugs (captropil),  to 14 
control blood pressure and other related diseases.   15 
 It has been shown that some peptides from fermented foods products can act by 16 
inhibiting the activity of the ACE enzyme, and, therefore, causing a lowering of blood 17 
pressure after intake (Hartmanna and Meisela, 2007). However, afterwards these 18 
peptides must be resistant to the action of gastric enzymes and must be absorbed to have 19 
an effect. Therefore, after isolating and identifying peptides with in vitro biological 20 
activity, in vivo studies are required to establish their true efficacy.  21 
 In wines, the first study focused on the occurrence of antihypertensive peptides 22 
was carried out by Takayanagi and Yokotsuka (1999), who determined the inhibitory 23 
activity of ACE (IACE) in two red wines and four white wines and in grapes of the red 24 
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Muscat Bailey A variety and during fermentation of the must. They showed a greater 1 
ACE inhibitor activity in red wines than white wines and a decrease in IACE during 2 
fermentation, although not providing any clear explanation for that.  3 
In long-term trials carried out on normotensive and spontaneously hypertensive 4 
rats, Perrot et al., (2003) showed that the extract from the low molecular weight fraction 5 
of a Champagne wine had antihypertensive activity in hypertensive rats but no effects in 6 
normotensive rats. However, owing to the complexity of this fraction, the authors 7 
indicated that this finding could not be only attributed to a single compound present in 8 
this fraction. Pozo-Bayón et al., (2005), showed that amino acids aspartic acid and/or 9 
asparagine and glutamic acid and/or glutamine and valine, formed part of 5 from the 6 10 
fractions from white and red wines with IACE activity, while threonine and alanine 11 
formed part of 4 of them.   12 
Due to the abundance of phenols and peptides in wines, it is difficult to attribute 13 
the IACE activity to one of these groups since both of them include individual 14 
compounds with this activity (Ling, 2003; Zhang et al., 2003). Although Pozo-Bayón et 15 
al., (2005) demonstrated that red wine fractions with high peptide and relative low 16 
phenolic contents highly contributed to IACE activity, it has also been found that red 17 
wines have greater ACE inhibitory activity than white wines (Takayanagi and 18 
Yokotsuka, 1999), suggesting the contribution of phenolic compounds to this activity. 19 
Lin (2003) has shown that phenols can be conjugated with proteins and produce non-20 
competitive inhibition of the ACE. It is, therefore, necessary to carry out more studies to 21 
identify the compounds responsible for this activity in wines. Recently, ACE inhibitory 22 
activity has also been found in peptides released from Saccharomyces cerevisiae in a 23 
model wine (Alcaide-Hidalgo et al., 2007b). In this assay, there were not phenolic 24 
compounds, thus the IACE activity was exclusively attributed to yeast peptides. 25 
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Moreover, the same rich peptides fractions also showed antioxidant activity, suggesting 1 
that peptides released by S. cerevisiae during autolysis under wine conditions could 2 
present multifunctional activities. 3 
Recently, prolylendopeptidase inhibitory peptides (PEP) have also been found in 4 
wines (Yanai et al., 2003). PEP may have a role in the degradation of biologically-5 
active peptides containing proline, such as oxytocin, vasopressin, P substance, 6 
bradykinin, neurotensins and angiotensins. Two inhibitory peptides have been isolated 7 
and characterized, Pep A (Val-Glu-Ile-Pro-Glu) and Pep B (Tyr, Pro, Ile, Pro, Phe). 8 
Both of them showed PEP inhibition thereby suppressing the degradation of 9 
neuropeptides, vasopressin, substance P and the fragments 8-13 of neurotensin, which 10 
are involved in memory and neural communication. 11 
 12 
CONCLUSIONS AND FUTURE OUTLOOK 13 
  14 
The aim of the present review has been to gather, from an integrated perspective, 15 
the scientific information concerning wine health and safety, a matter of emergent 16 
interest for researchers and consumers.  17 
 There is a wide variety of compounds that can affect wine safety. However to 18 
solve these problems there are different strategies currently available.  For example, it 19 
should be pointed out that a large part of today’s advance in control and prevention 20 
strategies for  wine contaminants has been possible thanks to the funding from several 21 
research frameworks (special EU research projects and other bilateral grants). Specific 22 
funds to increase the scientific knowledge related to the presence of OTA, biogenic 23 
amines and sulphur dioxide in wines, among others, have concluded in relevant 24 
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scientific outputs. As a consequence, the winemaking industry has specific knowledge 1 
currently available to control and/or prevent the formation of harmful compounds.  2 
 Great progress has also been done in recent years, trying to elucidate the 3 
compounds associated to the health benefits of moderate wine consumption and their 4 
action mode. Most of these advances have been focused on the study of wine phenolic 5 
compounds, confirming their key role in some healthy aspects derived from wine 6 
consumption.  7 
 Laboratory, but mainly clinical research, will continue exploring the efficacy of 8 
these important wine constituents in the human body, their bioavailability and action 9 
mechanisms. In the future, some promising applications of wine phenolics, such as their 10 
use in  prevention or conventional therapies to fight cancer and infections will gain 11 
interest. Clinical studies of how the human body interact with wine constituents and 12 
how such interactions can be modulated, will continue. Moreover, there is growing 13 
evidence of the biological properties of other wine constituents, such as peptides. 14 
Nevertheless, due to their complexity and low abundance in wines in comparison with 15 
other fermented foods, the scientific information regarding peptides as bioactive agents 16 
in wines is still scarce. Therefore, it is foreseeable that in the next years some progress 17 
related to the identity and health functions of specific wine peptides would increase.  18 
 As a summary, it is possible to confirm for consumers, that utmost efforts are 19 
being made in research, technology and administrative control to ensure that wine is a 20 
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Table 1. Summary of the most important measures to prevent or reduce OTA 1 
accumulation in wines, according the Code of Sound Vitivinicultural Practices of the 2 
OIV (OIV, 2005, Resolution VITI-OENO 1/2005)  3 
 4 
 
Cultivation practices in the vineyards 
- To train producers with regards to risk of mould and mycotoxins, the 
identification of ochratoxigenic fungus and period of infection, and knowledge 
of preventive measures to be applied to vineyard and wineries 
 
Practices at harvest 
-    To train the harvesting staff to reject rotten bunches, particularly those affected 
by dark brown black moulds 
-    To vinify the mechanical harvested grapes separately, when the sanitary quality 
of the crop is poor 
 
Treatment at the winery 
- To monitor, in large wineries and cooperatives, the sanitary quality of the grapes 
in order to favour with fair prIcing the sanitary quality of grapes, and to process 
the grapes accordingly 
- To avoid long periods of maceration and to use enological adsorbents, such as 
activated charcoal or yeast hulls, in red wine, and bentonite, in white wine, when 
the crop has a relevant percentage of rotten grapes 
- To perform a rapid grape drying and avoid water condensation overnight for 
grapes used in the vinification of dessert wines 
- To implement a complete HACCP plan, from the vine to the bottled wine or 




Table 2. Human intervention studies related to wine consumption. 1 
 2 




Positive outcomes Negative outcomes 
Lavy et al. (1994) 20 men -Red wine 
-White wine 
400 mL (40g 
ethanol/day) 
15  -Red wine: Increment in 
plasma HDLc and apo A1 
No changes in plasma total 
cholesterol, LDLc, VLDLc 
 






400 mL (40g 
ethanol/day) 
30  -Red wine/white wine: 
reduction of trombine-induced 
platelet aggregation and 
plasmatic levels of 
tromboxane B2 
 
-White wine: reduction of 
ADP-induced platelet 
aggregation 
-Enriched grape juice: 
Reduction of trombine-
induced platelet aggregation 
-Red wine: no reduction of ADP-
induced platelet aggregation 
Pellegrini et al. (1996) 11 men -Red wine 




-320 mL (30g 
ethanol/day) 




30  -Red wine / fruit 
juice+alcohol: Reduction in 
collagen-induced platelet 
aggregation and fribinogen 
levels 
No changes in ADP-induced 
platelet aggregation, t-PA antigen, 
vWF and plasminogen levels 








1 -Red wine: Inhibition of the 
LDL oxidation after 1 and 2 h 
of ingestion 
 












-1g/day= 375 ml red 
wine 
-1g/day  
-40g ethanol /day 
14 -Red wine, red wine 
polyphenols, red wine 
polyphenols+white wine: 
Reduction of plasma lipid 
peroxides, thiobarbituric acid-
reactive substances, and 
conjugated dienes. Increase in 
plasma and LDL polyphenols 
-White wine: Increase in 
thiobarbituric acid-reactive 
substances 
No changes in plasma 
triacylglycerol, LDL or HDL 
cholesterol 





113 mL 1  -Dealcoholized red wine: 
Increment in plasma  
antioxidant capacity and 
polyphenol content after 50 








Positive outcomes Negative outcomes 
Ursini et al. (1998) 9 men -fatty meal 
-red wine+ fatty 
meal 
300 mL 1 Red wine+fatty meal: 
Reduction of post-prandial 
plasma lipid hydroperoxide 
levels 
 
Djoussé et al. (1999) 13 men/women -Red wine+fatty 
meal (0.8 g fat/kg 
body weight)  
-Isocaloric 
beverage 
3mL/kg 1  No significant changes in FMD of 
the brachial artery after 
consumption of red wine +fatty 
meal 
Stein et al. (1999) 15 men/women 
with coronary 
artery disease 
Grape juice 7.7 1.2 mL/kg 15 Improvement of FMD and 
decrease of LDL susceptibility 
to oxidation 
 
Cuevas et al. (2000) 6 men -Red wine + fatty 
meal 
-Fatty meal 
240 mL 30 -Red wine: reduction in FMD 
of the brachial artery 
 
van deer Gaag et al. 
(2000a) 




 40 g ethanol /day 21 -Beer: Decrease in plasma 
homocysteine levels  
-Red wine/spirits: Increment in 
plasma homocysteine levels 
 
van deer Gaag et al. 
(2000b) 




40 g ethanol /day 21  No effets on the enzyme activities 
of serum glutathion peroxidase, 
erythrocyte glutathion reductase 
and superoxide dismutase, and 
plasma concentrations of -and -
tocopherol, lutein, zeaxantin, -
cryptoxanthin, lycopene and -
carotene  
Pignatelli et al. (2002) 20 men/women -Red wine 
-White wine 




Watzl et al. (2002) 6 men -Red wine 
-12% ethanol 
dilution 
500 mL 1  No effects on: TNF-α, IL-2, IL-4, 
phagocity activity of neutrophilis 
and lymphocyte proliferation 





-Red grape juice  
500 mL 15   No effects on: TNF-α, TNF-α 
mRNA, IL-2, IL-4, TGF-β,  
phagocity activity of neutrophilis, 
lymphocyte proliferation, lytic 
activity of natural killer cells, and 










Positive outcomes Negative outcomes 




(30 g ethanol/day) 
28  -Red wine: Reduction of the 
expression of VLA-4 in 
monocyte surface. 
-Both: Reduction of the TNF-
α induced adhesion of 
monocyte to an endothelial 
cell line. More pronounce for 
red wine. 
 




(30 g  tanol/day) 
28  -Red wine: reduction in the 
expression of LFA-1, Mac-1, 
VLA-4 and MCP-1 on 
monocyte surface. Reduction 
of serum levels of hs-CRP, 
VCAM-1 and ICAM-1. 
-Both: Reduction in C-reactive 
protein and IL1-α levels 
 
Papamichael et al. (2004) 16 men/women -Cigarette (1) 
-Cigarette (1) +red 
wine 




250 mL 1 Cigarette smoking + red wine 
or dealcholized red wine: No 
changes in flow mediated 
dilatation after 15, 30, and 60 
minutes after the inhalation of 
smoke compared to baseline 
levels 
 
Avellone et al. (2006) 48 men/women -Red wine 250 mL 30  Reduction of LDL/HDL ratio, 
fibrinogen, factor VII, C-
reactive protein, LDLox 
antibody. Increment in HDLc, 
apoA1, TGFβ1, t-PA, PAI  
and plasma antioxidant 
capacity 
 
Pignatelli et al. (2006) 20 men/women -Red wine 
-Alcohol wine 
300 mL  15  -Both: Increment in plasma 
antioxidant capacity and 
decrease in urine isoprotanes 
levels. 
 
Sacanella et al. (2007) 35 women -Red wine 
-White wine 
20g ethanol/day 30  
 
-Red wine: Reduction of 
serum levels of VCAM-1 and 
E-selectin.  
-Both: Increment in HDLc. 
Reduction of serum 
concentrations of hs-CRP, 









Positive outcomes Negative outcomes 
Vázquez-Agell et al. 
(2007) 








-Cava: Reduction of the 
expression LFA-1, VLA-4, 
SLe
x
 and CD40 on monocyte 
surface. Reduction of serum 
levels of hsCRP, ICAM-1, IL-
6, MCP-1 and CD40L  
-Gin:  Reduction of while only 
SLe
x
 on monocyte surface. 
-Both: reduction of serum 
levels of VCAM-1, E-selectin 
and P-selectin. 
 
Imhof et al. (2008) 49 men/women Red wine (12.5% 






alcohol; 160 mg/L 
polyphenols) 
-De-alcoholized 
red wine (275 
mg/L polyphenols) 
-De-alcoholized 
beer (171 mg/L 
polyphenols)    
-Water 
30g ethanol/day  for 
men and 20 g/d for 
women 
21 -Ethanol/ de-alcoholised red: 
Reduction on MCP-1-induced 
monocyte migration and in 
FMLP-induced migration  
No effects on MCP-1 receptor 
expression  







1  -Ethanol/wine: Increase in 
cardiac output and MSNA 
after 2 drinks of each. Increase 
in brachial artery diameter 
after both
 
one and two drinks. 
-Red wine: Increment in heart 
rate and attenuation in FMD 




*When not stated, studies were conducted on healthy subjects 3 
 4 
ADP: adosin diphosphate; ApoA1: apoliprotein A1; FMD: flow mediated vasodilation; FMLP:  N-formyl-methionyl-leucyl-phenylalanine; HDLc: high density lipoprotein cholesterol; hs-CRP: 5 
High-sensitivity C-reactive protein; ICAM-1: intercellular adhesion molecule-1; IL-2, IL1-α, IL-4, IL-6: interlukin 2, 1α, 4, 6; LDLc: low density lipoprotein cholesterol; LDLox: Oxidized 6 
LDL; LFA-1: lymphocyte function-associated antigen-1; Mac-1: CD11b/CD18; MCP-1: monocyte chemoattractant protein; MSNA: muscle sympathetic nerve activity; PAI : plasminogen 7 
activator inhibitor; SLex: Sialyl-Lewisx; TGFβ1: transforming growth factor β1; TNF-α: tumor necrosis factor α; t-PA: tissue-type plasminogen activator antigen; VCAM-1: vascular adhesion 8 
molecule-1; VLA-4: very late activation antigen-4; VLDLc: very low density lipoprotein cholesterol; vWF: von Willebrand factor 9 
 80 
FIGURE LEGENDS 1 
 2 
Figure 1. Chemical structure of ochratoxin A.  3 
Figure 2.  Chemical structure of main biogenic amines present in wine. 4 
Figure 3. Chemical structure of main non-flavanoid and flavanoid phenolic compounds 5 























Hydroxycinnamic acid R1 R2 R3 
    
p-Coumaric H OH H 
Caffeic OH OH H 
Ferulic OCH3 OH H 
Sinapic OCH3 OH OCH3 








Benzoic acid R1 R2 R3 R4 
     
p-Hydroxybenzoic H H OH H 
Protocatechuic H OH OH H 
Vanillic H OCH3 OH H 
Gallic H OH OH OH 
Syringic H OCH3 OH OCH3 
Salicilic OH H H H 
Gentisic OH H H OH 







Stilbene R1 R2 R3 
    
Trans-resveratrol H H H 
Trans-resveratrol-3-O-glucoside (piceid) H glc H 
Trans-resveratrol-2-C-glucoside H H glc 
Trans-astringin OH glc H 

















Flavan-3-ol R1 C-2 C-3 
    
(+)-Catechin H R S 
(+)-Gallocatechin OH R S 
(-)-Epicatechin H R R 
(-)-Epigallocatechin OH R R 

























Flavonol R1 R2 R3 
    
Kaempferol H H H 
Kaempferol-3-O-glucoside H H glc 
Kaempferol-3-O-galactoside H H gal 
Kaempferol-3-O-glucuronide H H gluc 
Quercetin OH H H 
Quercetin-3-O-glucoside OH H glc 
Quercetin-3-O-glucuronide OH H gluc 
Myricetin OH OH H 
Myricetin-3-O-glucoside OH OH glc 
Myricetin-3-O-glucuronide OH OH gluc 
Isorhamnetin OCH3 H H 
Isorhamnetin-3-O-glucoside OCH3 H glc 
    










Anthocyanidin R1 R2 
   
Cyanidin OH H 
Delphinidin OH OH 
Peonidin OCH3 H 
Petunidin OCH3 OH 
Malvidin OCH3 OCH3 















R3= -CO-CH3 -CO-CH=CH OH -CO-CH=CH OH
OH
(-acetyl) (-p-coumaroyl) (-caffeoyl) 




FLAVANOID PHENOLIC COMPOUNDS 
Flavonols 
Flavan-3-ols or flavanols 
Anthocyanins 
Figure 3 
